Abstract
Introduction
The prognosis of diffuse intrinsic pontine glioma (DIPG) is poor. The role of biopsy in DIPG remains controversial since the diagnosis may be established with imaging alone. Recent advances in understanding molecular biology and targeting of brain tumors have created a renewed interest in biopsy for DIPG. The Neurosurgery Working Group (NWG) of the SIOP-Europe Brain Tumor Group (BTG) undertook a survey among international pediatric neurosurgeons to define their current perceptions and practice regarding DIPG biopsy.
Methods
The NWG developed a 20-question survey which was emailed to neurosurgeons in the International Society for Pediatric Neurosurgery (ISPN). The questionnaire included questions on diagnosis, indications, and techniques for biopsy, clinical trials, and healthcare infrastructure.
Results
The survey was sent to 202 neurosurgeons and 73 (36%) responded. Consensus of > 75% agreement was reached for 12/20 questions, which included (1) radiological diagnosis of DIPG is sufficient outside a trial, (2) clinical trial–based DIPG biopsy is justified if molecular targets are investigated and may be used for treatment, and (3) morbidity/mortality data must be collected to define the risk:benefit ratio. The remaining 8/20 questions proved controversial and failed to reach consensus.
Conclusions
Routine DIPG biopsy continues to be debated. Most neurosurgeons agreed that DIPG biopsy within a clinical trial should be supported, with the aims of defining the procedure risks, improving understanding of tumor biology, and evaluating new treatment targets. Careful family counseling and consent remain important.
Similar content being viewed by others
References
Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the children’s cancer group. Neurosurgery 33(6):1026–1030
Epstein F, Constantini S (1996) Practical decisions in the treatment of pediatric brain stem tumors. Pediatr Neurosurg 24(1):24–34
Fisher PG, Breiter SN, Carson BS, Wharam MD, Williams JA, Weingart JD, Foer DR, Goldthwaite PT, Tihan T, Burger PC (2000) A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer 89(7):1569–1576
Frazier JL, Lee J, Thomale UW, Noggle JC, Cohen KJ, Jallo GI (2009) Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. J Neurosurg Pediatr 3(4):259–269
Jansen MH, van Zanten SEV, Aliaga ES, Heymans MW, Warmuth-Metz M, Hargrave D, van der Hoeven EJ, Gidding CE, de Bont ES, Eshghi OS, Reddingius R, Peeters CM, Meeteren AY S-v, Gooskens RH, Granzen B, Paardekooper GM, Janssens GO, Noske DP, Barkhof F, Kramm CM, Vandertop WP, Kaspers GJ, van Vuurden DG (2015) Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol 17(1):160–166
K.J. Cohen, N. Jabado, and J. Grill, “Neuro-oncology and new biologic insights. Is there a glimmer of hope ?,” vol. 19, no. December, pp. 1025–1034, 2017
Albright AL, Price RA, Guthkelch AN (1983) Brain stem gliomas of children. A clinicopathological study. Cancer 52(12):2313–2319
Constantini S, Epstein F (1996) Surgical indication and technical considerations in the management of benign brain stem gliomas. J Neuro-Oncol 28(2–3):193–205
Grill J, Puget S, Andreiuolo F, Philippe C, MacConaill L, Kieran MW (2012) Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma. Pediatr Blood Cancer 58(4):489–491
N. Gupta, L.C. Goumnerova, P. Manley, S.N. Chi, D. Neuberg, M. Puligandla, J. Fangusaro, S. Goldman, T. Tomita, T. Alden, A. DiPatri, J.B. Rubin, K. Gauvain, D. Limbrick, J. Leonard, J.R. Geyer, S. Leary, S. Browd, Z. Wang, S. Sood, A. Bendel, M. Nagib, S. Gardner, M.A. Karajannis, D. Harter, K. Ayyanar, W. Gump, D.C. Bowers, B. Weprin, T.J. MacDonald, D. Aguilera, B. Brahma, N.J. Robison, E. Kiehna, M. Krieger, E. Sandler, P. Aldana, Z. Khatib, J. Ragheb, S. Bhatia, S. Mueller, A. Banerjee, A.L. Bredlau, S. Gururangan, H. Fuchs, K.J. Cohen, G. Jallo, K. Dorris, M. Handler, M. Comito, M. Dias, K. Nazemi, L. Baird, J. Murray, N. Lindeman, J.L. Hornick, H. Malkin, C. Sinai, L. Greenspan, K.D. Wright, M. Prados, P. Bandopadhayay, K.L. Ligon, M.W. Kieran, “Neuro-oncology prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma,” vol. 20, no. May, pp. 1547–1555, 2018
T. J. MacDonald, “Diffuse intrinsic pontine glioma (DIPG): time to biopsy again?” Pediatr Blood Cancer, vol. 58, no. 4. United States, pp. 487–488, 2012
El Khouly FE, Van Zanten SEMV, Santa V, Lopez M (2019) Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand? J Neurooncol 145(1):177–184
Puget S, Beccaria K, Blauwblomme T, Roujeau T, James S, Grill J, Zerah M, Varlet P, Sainte-Rose C (2015) Biopsy in a series of 130 pediatric diffuse intrinsic pontine gliomas. Childs Nerv Syst 31(10):1773–1780
Chheda ZS, Kohanbash G, Okada K, Jahan N, Sidney J, Pecoraro M, Yang X, Carrera DA, Downey KM, Shrivastav S, Liu S, Lin Y, Lagisetti C, Chuntova P, Watchmaker PB, Mueller S, Pollack IF, Rajalingam R, Carcaboso AM, Mann M, Sette A, Garcia KC, Hou Y, Okada H (Jan. 2018) Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. J Exp Med 215(1):141–157
Castel D, Barret E, Picot S, Plessier A, Le Dret L, Nysom K, Huybrechts S, Capolino P, Le Deley MC, Vassal G, Puget S, Varlet P, Grill J, Debily MA (2017) DIPG-21. Genomic landscape of the first 100 tumors registered in the biological medicine for DIPG eradication (BIOMEDE) trial. Neuro Oncol 19(suppl_4):iv9–iv9
Tejada S, Alonso M, Patino A, Fueyo J, Gomez-Manzano C, Diez-Valle R (2017) Phase I trial of DNX-2401 for diffuse intrinsic pontine glioma newly diagnosed in pediatric patients. Neurosurgery
Pfaff E, El Damaty A, Balasubramanian GP, Blattner-Johnson M, Worst BC, Stark S, Witt H, Pajtler KW, van Tilburg CM, Witt R, Milde T, Jakobs M, Fiesel P, Frühwald MC, Driever PH, Thomale UW, Schuhmann MU, Metzler M, Bochennek K, Simon T, Dürken M, Karremann M, Knirsch S, Ebinger M, von Bueren AO, Pietsch T, Herold-Mende C, Reuss DE, Kiening K, Lichter P, Eggert A, Kramm CM, Pfister SM, Jones DTW, Bächli H, Witt O (2019) Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience. Eur J Cancer 114:27–35
Rutkowski S, Modena P, Williamson D, Kerl K, Nysom K, Pizer B, Bartels U, Puget S, Doz F, Michalski A, von Hoff K, Chevignard M, Avula S, Murray MJ, Schönberger S, Czech T, Meeteren AYN S-v, Kordes U, Kramm CM, van Vuurden DG, Hulleman E, Janssens GO, Solanki GA, van Veelen MC, Thomale U, Schuhmann MU, Jones C, Giangaspero F, Figarella-Branger D, Pietsch T, Clifford SC, Pfister SM, Van Gool SW (2018) Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group. Lancet Oncol 19(8):e419–e428
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tejada, S., Aquilina, K., Goodden, J. et al. Biopsy in diffuse pontine gliomas: expert neurosurgeon opinion—a survey from the SIOPE brain tumor group. Childs Nerv Syst 36, 705–711 (2020). https://doi.org/10.1007/s00381-020-04523-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-020-04523-8